전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,399 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleRochePreclinical

atezolizumab (Tecentriq, atezolizumab plus bevacizumab)

Hepatocellular Carcinoma; Hepatic Portal Vein Tumor Invasion · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#Antibody#Preclinical#monoclonal-antibody#HepatocellularCarcinoma+2
Trials 3Status Active
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, disitamab vedotin, sintilimab, capecitabine)

Rectal Cancer · Rectal Cancer

#RectalCancer#ADC#Phase2#antibody-drug-conjugate#RemeGen
Trials 3Status Recruiting
AntibodyLimited DatastaleMacroGenicsPhase 3

margetuximab (margetuximab)

Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#monoclonal-antibody#StageIIBreastCancer+1
Trials 3Status Active
CGTLimited DatastalePediatric Brain Tumor ConsortiumPhase 1

oncolytic HSV-1716 (oncolytic HSV-1716)

Recurrent Childhood Anaplastic Astrocytoma; Recurrent Childhood Anaplastic Oligoastrocytoma · Recurrent Childhood Anaplastic Astrocyto

#RecurrentChildhoodAnaplasticAstr#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Discontinued
AntibodyLimited DatastaleRochePhase 3

pertuzumab (Perjeta, pertuzumab [Perjeta])

Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase3#monoclonal-antibody#BreastCancer+1
Trials 3Status Active
ADCLimited DatastaleRochePhase 1

trastuzumab (Herceptin, trastuzumab-MCC-DM1)

Metastatic Breast Cancer · MET

#MET#ADC#Phase1#antibody-drug-conjugate#MetastaticBreastCancer+1
Trials 3Status Active
ADCLimited DatastaleMacroGenicsPhase 2

vobramitamab duocarmazine (vobramitamab duocarmazine)

Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#antibody-drug-conjugate#SquamousCellCarcinomaofHeadandNe+2
Trials 3Status Discontinued
AntibodyLimited DatastaleDavid HoPhase 1

10E8.4/iMab (10E8.4/iMab)

HIV-1-infection · HIV-1-infection

#HIV-1-infection#Antibody#Phase1#monoclonal-antibody#David
Trials 2Status Active
CGTLimited DatastaleMedical College of WisconsinPhase 2

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

Non Hodgkin Lymphoma (NHL); Mantle Cell Lymphoma (MCL) · Non Hodgkin Lymphoma (NHL)

#NonHodgkinLymphomaNHL#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

21.15.GPC3-CAR T cells (21.15.GPC3-CAR T cells)

Hepatoblastoma; Hepatocellular Carcinoma · Hepatoblastoma

#Hepatoblastoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
AntibodyLimited DatastaleJanssenPhase 2

daratumumab (Darzalex, 89Zr-DFO-daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#monoclonal-antibody#Janssen
Trials 2Status Discontinued
CGTAAVLimited DatastaleAdrenas Therapeutics IncPhase 2

AAV BBP-631 (AAV BBP-631)

Congenital Adrenal Hyperplasia · Congenital Adrenal Hyperplasia

#CongenitalAdrenalHyperplasia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
CGTAAVLimited DatastaleJanssen Research & Development,…Phase 2

AAV5-hRKp.RPGR (AAV5-hRKp.RPGR)

X-Linked Retinitis Pigmentosa · X-Linked Retinitis Pigmentosa

#X-LinkedRetinitisPigmentosa#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 2Status Active
CGTAAVLimited DatastaleNational Human Genome Research …Phase 2

AAV9-GLB1 (AAV9-GLB1)

Lysosomal Diseases; Gangliosidosis · Lysosomal Diseases

#LysosomalDiseases#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, AMG 386 and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 2Status Recruiting
CGTLimited DatastaleNational Heart, Lung, and Blood…Phase 2

ATLCAR.CD30 cells (ATLCAR.CD30 cells)

Lymphoma; Lymphoma, Non-Hodgkin · CD30

#CD30#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTAAVLimited DatastaleTerence FlottePreclinical

AXO-AAV-GM2 (AXO-AAV-GM2)

GM2 Gangliosidosis; Tay Sachs Disease · GM2 Gangliosidosis

#GM2Gangliosidosis#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleAstraZenecaPreclinical

AZD0754 (AZD0754)

Hepatocellular Carcinoma; Prostate Cancer · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
AntibodyLimited DatastaleGenmabPhase 2

Acasunlimab (Acasunlimab)

Non Small Cell Lung Cancer Metastatic · Non Small Cell Lung Cancer Metastatic

#NonSmallCellLungCancerMetastatic#Antibody#Phase2#monoclonal-antibody#Genmab
Trials 2Status Recruiting
AntibodyLimited DatastaleJanssenPhase 1

daratumumab (Darzalex, Actinium Ac 225-DOTA-Daratumumab)

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia · FRα

#FR#Antibody#Phase1#monoclonal-antibody#AcuteLymphoblasticLeukemia+2
Trials 2Status Recruiting

35 / 120 pages

← PreviousNext →